Sangi - Illumina or other sequencing is third party downstream process and then you have the propriety set of markers for disease and or progression of it. The question is why isn’t their capture of CTC getting adopted and what are the barriers to it. They can keep chucking money at it but unless they overcome these then they will be running out of money soon enough at the rate they are going.
Bantham - back in 2011/12 when this first got going, it was revolutionary tech back then. Does that still hold in the advances made in sequencing and other such tech. How does it compare to what Illumina and others want to do.
Same boat as you Nolupus.
blue83 - that pretty much hits nil on the head... where is this money being spent, almost £1.7 million a month going in a black hole without much return. That's the big problem here. Can they afford to keep spending at this rate. Company needs an urgent strategic review before they lose the ability to raise big cash. If you want to compete against the big boys, you must retain the ability to raise serious revenue.
Bojo - I am pondering, either this or Cizzle. will have to be one of those where you just invest and leave it for few years. it’s back to levels when you brought it to my attention in 2020, my worry is that there will be another considerable dilution late this year to have enough in reserves to make it through all of 2024.
As in you Nolupus? Happy new year btw.
Moab - I know why he wanted to do it, have an all encompassing eco system and maximising recurring revenue. I get all that. But priority should be adoption, get it adopted as quickly as possible first.
Cash burn means how quickly you will have to raise to keep the operation going. There comes a point where you have to justify all this money being spent, its not an endless pit.
Moab - Moving away to fitting in with third party should have been the priority all along and how much that is going to lessen the spend is yet to be seen.
what a shambles and I never thought I would say this about ANGLE... They need at least £20 odd million a year to keep operations going and revenue projection for 2023 is now £0.5 million!! What are they spending this £20+ million a year on?
Struggling to see how it can justify the current mcap. They will need a large capital raise this year to keep the operations as is in 2024.
First, this is an excellent thread of rival views and thoughts… very informative so well done everyone.
I am in Golden’s camp, ingenuity is/was an opportunistic play which didn’t kick off quickly enough during the covid bull market, and now firmly caught in the tech bear market. Now the fundamentals are at play and frankly they just don’t stack up. What’s the USP of Ingenuity that others can’t provide. After all it’s a back end system that most online retailers either develop or use third party tools. Once you put in this perspective then you begin to realise that the game is up for Ingenuity. It does not justify the capex when the returns are so small. Scale it back and focus on other divisions.
Will thg ever be cash flow positive? Therein explains why it is where it is in a bear market.
give her family a secret share of phulbari... you will see the mine given the go ahead pronto :)
He did indeed
At some point the money will run out and the peanut commision for selling Avon products will not be able to sustain the company. Who will fund the new phase2?
The RNS is what you call a **** sandwich.
Matty - what was the mcap before the corporate action?
Why does it concern Moulding how potential new owners run the business….. just take the money and get lost.
Ste2000’s description of biggest act of corporate suicide is very apt. Million households coming looking for new fixed rate deals next year in addition to first time buyers… budgets will be squeezed for years to come. The implications will be felt for longer and companies like THG will see it in their earnings.
What they desperately need is expansion in overseas earnings.
Nolupus - What's your take on this now?
Jas - as a rule, never invest in a company where the directors sell out. It will serve you well in keeping your cash in tact.
They said that they are in deflationary period since April with regards to whey. Later on they said that they don't buy spot price, they usually buy quarter or more usually half year earlier and spot price if they need to top up. So presumably, the first 6 months of this year they paid lot less, because of the purchase at the end of last year, which means the whey increase hasn't really been factored in and only in this quarter or the next that this will show up.